CDIFFENSE Trademark

Trademark Overview

On Thursday, July 11, 2013, a trademark application was filed for CDIFFENSE with the United States Patent and Trademark Office. The USPTO has given the CDIFFENSE trademark a serial number of 86008075. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 13, 2017. This trademark is owned by Sanofi Pasteur. The CDIFFENSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals, vaccines and clinical trials
cdiffense

General Information

Serial Number86008075
Word MarkCDIFFENSE
Filing DateThursday, July 11, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 13, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2013

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals, vaccines and clinical trials
Pseudo MarkC DIFFENSE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 19, 2013
Primary Code042
First Use Anywhere DateThursday, October 1, 2015
First Use In Commerce DateThursday, October 1, 2015

Trademark Owner History

Party NameSanofi Pasteur
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address69007 Lyon
FR
Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address69007 Lyon
FR

Trademark Events

Event DateEvent Description
Monday, March 13, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 13, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 15, 2016NON-FINAL ACTION E-MAILED
Monday, August 15, 2016SU - NON-FINAL ACTION - WRITTEN
Saturday, August 13, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 27, 2016USE AMENDMENT FILED
Wednesday, July 27, 2016TEAS STATEMENT OF USE RECEIVED
Wednesday, January 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 12, 2016EXTENSION 4 GRANTED
Wednesday, January 6, 2016EXTENSION 4 FILED
Wednesday, January 6, 2016TEAS EXTENSION RECEIVED
Tuesday, July 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 18, 2015EXTENSION 3 GRANTED
Monday, July 13, 2015EXTENSION 3 FILED
Monday, July 13, 2015TEAS EXTENSION RECEIVED
Thursday, March 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 11, 2015EXTENSION 2 GRANTED
Friday, January 23, 2015EXTENSION 2 FILED
Tuesday, March 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 23, 2015TEAS EXTENSION RECEIVED
Tuesday, June 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 20, 2014EXTENSION 1 GRANTED
Friday, June 20, 2014EXTENSION 1 FILED
Friday, June 20, 2014TEAS EXTENSION RECEIVED
Tuesday, January 28, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2013ASSIGNED TO EXAMINER
Saturday, July 20, 2013NOTICE OF PSEUDO MARK E-MAILED
Friday, July 19, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 15, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

cdiffense pharmaceuticals vaccines clinical trials field information medical scientific research providing